user

Managing Urological Disorders in Multiple Sclerosis Patients: A Review of Available and Emerging Therapies

被引：9
|
作者：
Bientinesi, Riccardo [1 ]
Gandi, Carlo [1 ]
Bassi, PierFrancesco [1 ]
机构：
[1] Catholic Univ, Agostino Gemelli Hosp Fdn IRCCS, Dept Urol, Med Sch, Rome, Italy
来源：
INTERNATIONAL NEUROUROLOGY JOURNAL | 2020年 / 24卷 / 02期
关键词：
Multiple sclerosis; Lower urinary tract symptoms; Urinary incontinence; Neurogenic detrusor overactivity; DETRUSOR-SPHINCTER DYSSYNERGIA; URINARY-TRACT DYSFUNCTION; TIBIAL NERVE-STIMULATION; SPINAL-CORD-INJURY; BOTULINUM-A TOXIN; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; SEXUAL DYSFUNCTION; DOUBLE-BLIND; ELECTRICAL-STIMULATION;
D O I：
10.5213/inj.2040028.014
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Multiple sclerosis (MS) is a progressive neurological autoimmune disease with a diverse range of urological symptomatology, and most MS patients experience 1 or more moderate to severe urinary symptoms, as well as bladder and/or sexual disorders. Urologists play the director's role in evaluating and treating these patients. Therefore, identifying the proper evaluation tools and the most suitable therapeutic options for specific patients requires a thorough understanding of this disease process.
引用
收藏
页码：118 / 126
页数：9
相关论文
共 50 条
  • [41] Current and Emerging Therapies for the Treatment of Multiple Sclerosis: Focus on Cladribine
    Schreiner, Teri L.
    Miravalle, Augusto
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2012, 4 : 1 - 14
  • [42] Neuro-urological management for patients with multiple sclerosis
    Piehler, D.
    Efimova, S.
    Dressl, A.
    Zettl, U. K.
    Klebingat, K.-J.
    UROLOGE, 2007, 46 (09): : 1208 - 1209
  • [43] Emerging disease-modifying oral therapies for multiple sclerosis
    Losy, Jacek
    Kalinowska-Lyszczarz, Alicja
    JOURNAL OF NEUROIMMUNOLOGY, 2011, 231 (1-2) : 15 - 22
  • [44] Current and emerging treatments for relapsing multiple sclerosis in Argentinian patients: a review
    Rojas, Juan I.
    Patrucco, Liliana
    Cristiano, Edgardo
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2014, 4 : 103 - 109
  • [45] Guidance on new therapies in multiple sclerosis patients
    Clanet, M
    Comi, G
    Fernandez, O
    Gonsette, RE
    Hartung, HP
    Hommes, O
    SoelbergSorensen, P
    Thompson, EJ
    LANCET, 1996, 348 (9020): : 136 - 136
  • [46] Cost of managing relapses in patients with multiple sclerosis
    Rao, S
    Yu, H
    ANNALS OF NEUROLOGY, 2004, 56 : S2 - S2
  • [47] Pathogenetic treatment of multiple sclerosis: Emerging therapies that modify the course of the disease
    Bomprezzi, R
    Ristori, G
    Kovacs, D
    Bagnato, F
    Gherardi, M
    Buttinelli, C
    Salvetti, M
    Pozzilli, C
    Fieschi, C
    GIORNALE DI NEUROPSICOFARMACOLOGIA, 1997, 19 (04): : 79 - 81
  • [48] UROLOGICAL PROBLEMS IN PATIENTS SUFFERING FROM MULTIPLE-SCLEROSIS
    MORIEL, EZ
    RABEY, JM
    FARKAS, A
    STEIFLER, M
    FIRSTATER, M
    ANNALES D UROLOGIE, 1979, 13 (02) : 111 - 113
  • [49] Incidence of the urological tumours in patients suffering from multiple sclerosis
    Krhut, J.
    Hradilek, P.
    Nemec, D.
    Tvrdik, J.
    Zapletalova, O.
    Zvara, P.
    ACTA NEUROLOGICA SCANDINAVICA, 2014, 130 (03): : 193 - 196
  • [50] UROLOGICAL PROBLEMS IN PATIENTS SUFFERING FROM MULTIPLE-SCLEROSIS
    MORIEL, EZ
    RABEY, JM
    FARKAS, A
    STEIFLER, M
    FIRSTATER, M
    SEMAINE DES HOPITAUX, 1979, 55 (41-4): : 1921 - 1923
12345